CDK9-IN-9
| Code | Size | Price |
|---|
| TAR-T10747-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
CDK9-IN-9 is a potent and selective CDK9 inhibitor (IC50: 1.8 nM) with anti-cancer activity. It inhibits CDK2 (IC50: 155 nM).
CAS:
2246956-84-1
Formula:
C22H23F2N5O2S
Molecular Weight:
459.52
Pathway:
Cell Cycle/Checkpoint
Purity:
0.98
SMILES:
CS(=N)(=O)Cc1cc2Nc3ncc(F)c(n3)-c3ccc(F)c(NCCCCOc(c1)c2)c3
Target:
CDK
References
1. Ulrich L?CKING, et al. Novel ptefb inhibiting macrocyclic compounds. WO2018177889A1.